Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intrinsic defence capacity and therapeutic potential of natriuretic peptides in pulmonary hypertension associated with lung fibrosis

Published:2014-06-25 Issue:14 Volume:171 Page:3463-3475
ISSN:0007-1188
Container-title:British Journal of Pharmacology
language:en
Short-container-title:Br J Pharmacol

Author:

Baliga R S¹,Scotton C J²,Trinder S L³,Chambers R C²,MacAllister R J³,Hobbs A J¹³

Affiliation:

1. William Harvey Research Institute, Barts & The London School of Medicine; Queen Mary University of London; Charterhouse Square London UK

2. Centre for Respiratory Research; University College London; The Rayne Building London UK

3. Centre for Clinical Pharmacology; University College London; The Rayne Building London UK

Funder

British Lung Foundation

Medical Research Council

Publisher

Wiley

Subject

Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bph.12694/fullpdf

Reference61 articles.

1. The Concise Guide to PHARMACOLOGY 2013/14: Catalytic Receptors;Alexander;Br J Pharmacol,2013

2. Synergy between natriuretic peptides and phosphodiesterase 5 inhibitors ameliorates pulmonary arterial hypertension;Baliga;Am J Respir Crit Care Med,2008

3. Transforming growth factor beta 1 (TGF-beta 1) in atrial fibrillation and acute congestive heart failure;Behnes;Clin Res Cardiol,2011

4. Pulmonary hypertension in interstitial lung disease;Behr;Eur Respir J,2008

5. Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use;Bender;Pharmacol Rev,2006

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitinase 3 like 1 contributes to the development of pulmonary vascular remodeling in pulmonary hypertension;JCI Insight;2022-09-22

2. Multidrug resistance proteins preferentially regulate natriuretic peptide‐driven cGMP signalling in the heart and vasculature;British Journal of Pharmacology;2021-07-13

3. Loss of immune homeostasis in patients with idiopathic pulmonary arterial hypertension;Thorax;2021-05-07

4. Dysregulation of BMP9/BMPR2/SMAD signalling pathway contributes to pulmonary fibrosis and pulmonary hypertension induced by bleomycin in rats;British Journal of Pharmacology;2020-11-09

5. Targeting Neprilysin (NEP) pathways: A potential new hope to defeat COVID-19 ghost;Biochemical Pharmacology;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3